This website is intended for patients & providers in the USA only. Prescribing Information.
This website is intended for patients & providers outside of the USA. Prescribing Information.
  1. Bioness Inc. Internal Patient Survey. Completed March, 2021; Data on file.
  2. Oswald J, Shahi V, Chakravarthy KV. PProspective, multicenter, randomized, double-blinded, partial crossover study to assess the safety and efficacy of the novel neuromodulation system in the treatment of patients with chronic pain of peripheral nerve origin. Pain Manage. 2019;9(6):551-8. doi:10.2217/pmt-2019-0028
  3. Deer T, Pope J, Benyamin R, et al. Prospective, Multicenter, Randomized, Double-Blinded, Partial Crossover Study to Assess the Safety and Efficacy of the Novel Neuromodulation System in the Treatment of Patients With Chronic Pain of Peripheral Nerve Origin.
    Neuromodulation. 2016;19(1):91-100. doi:10.1111/ner.12381
  4. Dahlhamer J, Lucas J, Zelaya, C, et al. Prevalence of chronic pain and high-impact chronic pain among adults – United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(36):1001-6. doi:10.15585/mmwr.mm6736a2